Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P13
Within normal range
vs 2Y Ago
-6.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -600.00% |
| Q3 2025 | 107.19% |
| Q2 2025 | -549.23% |
| Q1 2025 | 3150.00% |
| Q4 2024 | -90.00% |
| Q3 2024 | 124.10% |
| Q2 2024 | -59.62% |
| Q1 2024 | -1203.26% |
| Q4 2023 | 97.30% |
| Q3 2023 | -150.85% |
| Q2 2023 | 69.43% |
| Q1 2023 | 10.23% |
| Q4 2022 | -667.86% |
| Q3 2022 | 96.87% |
| Q2 2022 | 75.07% |
| Q1 2022 | -310.76% |
| Q4 2021 | 97.99% |
| Q3 2021 | -2586.42% |
| Q2 2021 | 42.55% |
| Q1 2021 | -95.83% |
| Q4 2020 | -105.71% |
| Q3 2020 | -25.00% |
| Q2 2020 | 81.46% |
| Q1 2020 | -1158.33% |
| Q4 2019 | 96.27% |
| Q3 2019 | 69.41% |
| Q2 2019 | -111.90% |
| Q1 2019 | 31.00% |
| Q4 2018 | 63.28% |
| Q3 2018 | -743.06% |
| Q2 2018 | 106.41% |
| Q1 2018 | 73.38% |
| Q4 2017 | 11.13% |
| Q3 2017 | 72.76% |
| Q2 2017 | 51.34% |
| Q1 2017 | 15.01% |
| Q4 2016 | 60.73% |
| Q3 2016 | 72.68% |
| Q2 2016 | -5.15% |
| Q1 2016 | -32.87% |